187 related articles for article (PubMed ID: 25267010)
21. Establishment and characterization of a new triple-negative canine mammary cancer cell line.
Zhang H; Pei S; Zhou B; Wang H; Du H; Zhang D; Lin D
Tissue Cell; 2018 Oct; 54():10-19. PubMed ID: 30309498
[TBL] [Abstract][Full Text] [Related]
22. Significance of caveolin-1 and matrix metalloproteinase 14 gene expression in canine mammary tumours.
Ebisawa M; Iwano H; Nishikawa M; Tochigi Y; Komatsu T; Endou Y; Hirayama K; Taniyama H; Kadosawa T; Yokota H
Vet J; 2015 Nov; 206(2):191-6. PubMed ID: 26364240
[TBL] [Abstract][Full Text] [Related]
23. Molecular iodine/doxorubicin neoadjuvant treatment impair invasive capacity and attenuate side effect in canine mammary cancer.
Zambrano-Estrada X; Landaverde-Quiroz B; Dueñas-Bocanegra AA; De Paz-Campos MA; Hernández-Alberto G; Solorio-Perusquia B; Trejo-Mandujano M; Pérez-Guerrero L; Delgado-González E; Anguiano B; Aceves C
BMC Vet Res; 2018 Mar; 14(1):87. PubMed ID: 29530037
[TBL] [Abstract][Full Text] [Related]
24. Establishment and characterization of cell lines from chromosomal instable colorectal cancer.
Maletzki C; Gock M; Randow M; Klar E; Huehns M; Prall F; Linnebacher M
World J Gastroenterol; 2015 Jan; 21(1):164-76. PubMed ID: 25574089
[TBL] [Abstract][Full Text] [Related]
25. Downregulation of the KLF4 transcription factor inhibits the proliferation and migration of canine mammary tumor cells.
Tien YT; Chang MH; Chu PY; Lin CS; Liu CH; Liao AT
Vet J; 2015 Aug; 205(2):244-53. PubMed ID: 25616642
[TBL] [Abstract][Full Text] [Related]
26. Aldoxorubicin-loaded nanofibers are cytotoxic for canine mammary carcinoma and osteosarcoma cell lines in vitro: A short communication.
Stokol T; Wan C; Blakely R; Bellat V; Law B
Res Vet Sci; 2020 Feb; 128():86-89. PubMed ID: 31760317
[TBL] [Abstract][Full Text] [Related]
27. A Comparative Study on the In Vitro Effects of the DNA Methyltransferase Inhibitor 5-Azacytidine (5-AzaC) in Breast/Mammary Cancer of Different Mammalian Species.
Harman RM; Curtis TM; Argyle DJ; Coonrod SA; Van de Walle GR
J Mammary Gland Biol Neoplasia; 2016 Jun; 21(1-2):51-66. PubMed ID: 27002722
[TBL] [Abstract][Full Text] [Related]
28. In vitro and in vivo antiproliferative activity of metformin on stem-like cells isolated from spontaneous canine mammary carcinomas: translational implications for human tumors.
Barbieri F; Thellung S; Ratto A; Carra E; Marini V; Fucile C; Bajetto A; Pattarozzi A; Würth R; Gatti M; Campanella C; Vito G; Mattioli F; Pagano A; Daga A; Ferrari A; Florio T
BMC Cancer; 2015 Apr; 15():228. PubMed ID: 25884842
[TBL] [Abstract][Full Text] [Related]
29. In vitro study to assess the efficacy of CDK4/6 inhibitor Palbociclib (PD-0332991) for treating canine mammary tumours.
Schoos A; Knab VM; Gabriel C; Tripolt S; Wagner DA; Bauder B; Url A; Fux DA
Vet Comp Oncol; 2019 Dec; 17(4):507-521. PubMed ID: 31207004
[TBL] [Abstract][Full Text] [Related]
30. ZEB1 and ZEB2 transcription factors are potential therapeutic targets of canine mammary cancer cells.
Xavier PLP; Cordeiro YG; Rochetti AL; Sangalli JR; Zuccari DAPC; Silveira JC; Bressan FF; Fukumasu H
Vet Comp Oncol; 2018 Dec; 16(4):596-605. PubMed ID: 30047225
[TBL] [Abstract][Full Text] [Related]
31. In vitro efficacy of chemotherapeutics as determined by 50% inhibitory concentrations in cell cultures of mammary gland tumors obtained from dogs.
Simon D; Knebel JW; Baumgartner W; Aufderheide M; Meyer-Lindenberg A; Nolte I
Am J Vet Res; 2001 Nov; 62(11):1825-30. PubMed ID: 11703031
[TBL] [Abstract][Full Text] [Related]
32. Expression and the molecular forms of neutrophil gelatinase-associated lipocalin and matrix metalloproteinase 9 in canine mammary tumours.
Chen YC; Chang SC; Huang YH; Lee YJ; Chang CC; Liao JW; Hsu WL
Vet Comp Oncol; 2019 Sep; 17(3):427-438. PubMed ID: 31050171
[TBL] [Abstract][Full Text] [Related]
33. High drug efflux pump capacity and low DNA damage response induce doxorubicin resistance in canine hemangiosarcoma cell lines.
Morita A; Aoshima K; Gulay KCM; Onishi S; Shibata Y; Yasui H; Kobayashi A; Kimura T
Res Vet Sci; 2019 Dec; 127():1-10. PubMed ID: 31648115
[TBL] [Abstract][Full Text] [Related]
34. Survivin and related proteins in canine mammary tumors: immunohistochemical expression.
Bongiovanni L; Romanucci M; Malatesta D; D'Andrea A; Ciccarelli A; Della Salda L
Vet Pathol; 2015 Mar; 52(2):269-75. PubMed ID: 24686389
[TBL] [Abstract][Full Text] [Related]
35. Anti-neoplastic effects of topoisomerase inhibitors in canine mammary carcinoma, melanoma, and osteosarcoma cell lines.
Ong SM; Yamamoto H; Saeki K; Tanaka Y; Yoshitake R; Nishimura R; Nakagawa T
Jpn J Vet Res; 2017 Feb; 65(1):17-28. PubMed ID: 29791117
[TBL] [Abstract][Full Text] [Related]
36. IFN-λ Modulates the Migratory Capacity of Canine Mammary Tumor Cells via Regulation of the Expression of Matrix Metalloproteinases and Their Inhibitors.
Pingwara R; Kosmala D; Woźniak N; Orzechowski A; Mucha J
Cells; 2021 Apr; 10(5):. PubMed ID: 33922837
[TBL] [Abstract][Full Text] [Related]
37. Simvastatin exhibits antiproliferative effects on spheres derived from canine mammary carcinoma cells.
Torres CG; Olivares A; Stoore C
Oncol Rep; 2015 May; 33(5):2235-44. PubMed ID: 25778435
[TBL] [Abstract][Full Text] [Related]
38. Tumor slices as a model to evaluate doxorubicin in vitro treatment and expression of trios of genes PRSS11, MTSS1, CLPTM1 and PRSS11, MTSS1, SMYD2 in canine mammary gland cancer.
Sobral RA; Honda ST; Katayama ML; Brentani H; Brentani MM; Patrão DF; Folgueira MA
Acta Vet Scand; 2008 Jul; 50(1):27. PubMed ID: 18601734
[TBL] [Abstract][Full Text] [Related]
39. Molecular iodine impairs chemoresistance mechanisms, enhances doxorubicin retention and induces downregulation of the CD44+/CD24+ and E-cadherin+/vimentin+ subpopulations in MCF-7 cells resistant to low doses of doxorubicin.
Bontempo A; Ugalde-Villanueva B; Delgado-González E; Rodríguez ÁL; Aceves C
Oncol Rep; 2017 Nov; 38(5):2867-2876. PubMed ID: 28901484
[TBL] [Abstract][Full Text] [Related]
40. Canine mammary carcinoma cell line are resistant to chemosensitizers: verapamil and cyclosporin A.
Król M; Pawłowski KM; Majchrzak K; Mucha J; Motyl T
Pol J Vet Sci; 2014; 17(1):9-17. PubMed ID: 24724465
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]